1 Report Overview 1.1 Research Scope 1.2 Market Segment by Type 1.2.1 Global Pediatric Vaccines Market Size Growth Rate by Type (2017 VS 2021 VS 2028) 1.2.2 Diphtheria 1.2.3 Influenza 1.2.4 Hepatitis 1.2.5 Pneumococcal Diseases 1.2.6 Meningococcal Diseases 1.2.7 Others 1.3 Market Segment by Application 1.3.1 Global Pediatric Vaccines Market Share by Application (2017 VS 2021 VS 2028) 1.3.2 Newborn 1.3.3 Infant 1.3.4 Child 1.3.5 Dolescent 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Pediatric Vaccines Market Size (2017-2028) 2.1.1 Global Pediatric Vaccines Revenue (2017-2028) 2.1.2 Global Pediatric Vaccines Sales (2017-2028) 2.2 Global Pediatric Vaccines Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.2.1 Global Pediatric Vaccines Sales by Regions (2017-2022) 2.2.2 Global Pediatric Vaccines Revenue by Regions (2017-2022) 2.3 Global Pediatric Vaccines Market Size Forecast by Region 2.3.1 Global Pediatric Vaccines Sales Forecast by Region (2023-2028) 2.3.2 Global Pediatric Vaccines Revenue Forecast by Region (2023-2028) 2.4 Global Top Pediatric Vaccines Regions (Countries) Ranking by Market Size 2.5 Pediatric Vaccines Market Dynamics 2.5.1 Pediatric Vaccines Market Trends 2.5.2 Pediatric Vaccines Market Drivers 2.5.3 Pediatric Vaccines Market Challenges 2.5.4 Pediatric Vaccines Market Restraints 3 Competitive Landscape by Manufacturers 3.1 Global Top Pediatric Vaccines Manufacturers by Sales (2017-2022) 3.1.1 Global Pediatric Vaccines Sales by Manufacturers (2017-2022) 3.1.2 Global Pediatric Vaccines Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global 5 and 10 Largest Manufacturers by Pediatric Vaccines Sales in 2021 3.2 Global Top Manufacturers Pediatric Vaccines by Revenue 3.2.1 Global Pediatric Vaccines Revenue by Manufacturers (2017-2022) 3.2.2 Top Pediatric Vaccines Manufacturers Covered: Ranking by Revenue 3.2.3 Global Pediatric Vaccines Revenue Share by Manufacturers (2017-2022) 3.2.4 Global Pediatric Vaccines Market Concentration Ratio (CR5 and HHI) 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2021) 3.4 Global Pediatric Vaccines Average Selling Price (ASP) by Manufacturers 3.5 Key Manufacturers Pediatric Vaccines Plants/Factories Distribution and Area Served 3.6 Date of Key Manufacturers Enter into Pediatric Vaccines Market 3.7 Key Manufacturers Pediatric Vaccines Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Pediatric Vaccines Market Size by Type 4.1 Global Pediatric Vaccines Historic Market Review by Type (2017-2022) 4.1.1 Global Pediatric Vaccines Sales Market Share by Type (2017-2022) 4.1.2 Global Pediatric Vaccines Revenue Market Share by Type (2017-2022) 4.1.3 Pediatric Vaccines Price by Type (2017-2022) 4.2 Global Pediatric Vaccines Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global Pediatric Vaccines Sales Forecast by Type (2023-2028) 4.2.2 Global Pediatric Vaccines Revenue Forecast by Type (2023-2028) 4.2.3 Pediatric Vaccines Price Forecast by Type (2023-2028) 5 Global Pediatric Vaccines Market Size by Application 5.1 Global Pediatric Vaccines Historic Market Review by Application (2017-2022) 5.1.1 Global Pediatric Vaccines Sales Market Share by Application (2017-2022) 5.1.2 Global Pediatric Vaccines Revenue Market Share by Application (2017-2022) 5.1.3 Pediatric Vaccines Price by Application (2017-2022) 5.2 Global Pediatric Vaccines Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global Pediatric Vaccines Sales Forecast by Application (2023-2028) 5.2.2 Global Pediatric Vaccines Revenue Forecast by Application (2023-2028) 5.2.3 Pediatric Vaccines Price Forecast by Application (2023-2028) 6 North America 6.1 North America Pediatric Vaccines Sales Breakdown by Company 6.1.1 North America Pediatric Vaccines Sales by Company (2017-2022) 6.1.2 North America Pediatric Vaccines Revenue by Company (2017-2022) 6.2 North America Pediatric Vaccines Market Size by Type 6.2.1 North America Pediatric Vaccines Sales by Type (2017-2028) 6.2.2 North America Pediatric Vaccines Revenue by Type (2017-2028) 6.3 North America Pediatric Vaccines Market Size by Application 6.3.1 North America Pediatric Vaccines Sales by Application (2017-2028) 6.3.2 North America Pediatric Vaccines Revenue by Application (2017-2028) 6.4 North America Pediatric Vaccines Market Size by Country 6.4.1 North America Pediatric Vaccines Sales by Country (2017-2028) 6.4.2 North America Pediatric Vaccines Revenue by Country (2017-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Pediatric Vaccines Sales Breakdown by Company 7.1.1 Europe Pediatric Vaccines Sales by Company (2017-2022) 7.1.2 Europe Pediatric Vaccines Revenue by Company (2017-2022) 7.2 Europe Pediatric Vaccines Market Size by Type 7.2.1 Europe Pediatric Vaccines Sales by Type (2017-2028) 7.2.2 Europe Pediatric Vaccines Revenue by Type (2017-2028) 7.3 Europe Pediatric Vaccines Market Size by Application 7.3.1 Europe Pediatric Vaccines Sales by Application (2017-2028) 7.3.2 Europe Pediatric Vaccines Revenue by Application (2017-2028) 7.4 Europe Pediatric Vaccines Market Size by Country 7.4.1 Europe Pediatric Vaccines Sales by Country (2017-2028) 7.4.2 Europe Pediatric Vaccines Revenue by Country (2017-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 8 Asia Pacific 8.1 Asia Pacific Pediatric Vaccines Sales Breakdown by Company 8.1.1 Asia Pacific Pediatric Vaccines Sales by Company (2017-2022) 8.1.2 Asia Pacific Pediatric Vaccines Revenue by Company (2017-2022) 8.2 Asia Pacific Pediatric Vaccines Market Size by Type 8.2.1 Asia Pacific Pediatric Vaccines Sales by Type (2017-2028) 8.2.2 Asia Pacific Pediatric Vaccines Revenue by Type (2017-2028) 8.3 Asia Pacific Pediatric Vaccines Market Size by Application 8.3.1 Asia Pacific Pediatric Vaccines Sales by Application (2017-2028) 8.3.2 Asia Pacific Pediatric Vaccines Revenue by Application (2017-2028) 8.4 Asia Pacific Pediatric Vaccines Market Size by Region 8.4.1 Asia Pacific Pediatric Vaccines Sales by Region 8.4.2 Asia Pacific Pediatric Vaccines Revenue by Region 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 India 8.4.7 Australia 8.4.8 China Taiwan 8.4.9 Indonesia 8.4.10 Thailand 8.4.11 Malaysia 9 Latin America 9.1 Latin America Pediatric Vaccines Sales Breakdown by Company 9.1.1 Latin America Pediatric Vaccines Sales by Company (2017-2022) 9.1.2 Latin America Pediatric Vaccines Revenue by Company (2017-2022) 9.2 Latin America Pediatric Vaccines Market Size by Type 9.2.1 Latin America Pediatric Vaccines Sales by Type (2017-2028) 9.2.2 Latin America Pediatric Vaccines Revenue by Type (2017-2028) 9.3 Latin America Pediatric Vaccines Market Size by Application 9.3.1 Latin America Pediatric Vaccines Sales by Application (2017-2028) 9.3.2 Latin America Pediatric Vaccines Revenue by Application (2017-2028) 9.4 Latin America Pediatric Vaccines Market Size by Country 9.4.1 Latin America Pediatric Vaccines Sales by Country (2017-2028) 9.4.2 Latin America Pediatric Vaccines Revenue by Country (2017-2028) 9.4.3 Mexico 9.4.4 Brazil 9.4.5 Argentina 9.4.6 Colombia 10 Middle East and Africa 10.1 Middle East and Africa Pediatric Vaccines Sales Breakdown by Company 10.1.1 Middle East and Africa Pediatric Vaccines Sales by Company (2017-2022) 10.1.2 Middle East and Africa Pediatric Vaccines Revenue by Company (2017-2022) 10.2 Middle East and Africa Pediatric Vaccines Market Size by Type 10.2.1 Middle East and Africa Pediatric Vaccines Sales by Type (2017-2028) 10.2.2 Middle East and Africa Pediatric Vaccines Revenue by Type (2017-2028) 10.3 Middle East and Africa Pediatric Vaccines Market Size by Application 10.3.1 Middle East and Africa Pediatric Vaccines Sales by Application (2017-2028) 10.3.2 Middle East and Africa Pediatric Vaccines Revenue by Application (2017-2028) 10.4 Middle East and Africa Pediatric Vaccines Market Size by Country 10.4.1 Middle East and Africa Pediatric Vaccines Sales by Country (2017-2028) 10.4.2 Middle East and Africa Pediatric Vaccines Revenue by Country (2017-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Company Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Corporation Information 11.1.2 GlaxoSmithKline Overview 11.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.1.4 GlaxoSmithKline Pediatric Vaccines Products and Services 11.1.5 GlaxoSmithKline Pediatric Vaccines SWOT Analysis 11.1.6 GlaxoSmithKline Recent Developments 11.2 Merck 11.2.1 Merck Corporation Information 11.2.2 Merck Overview 11.2.3 Merck Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.2.4 Merck Pediatric Vaccines Products and Services 11.2.5 Merck Pediatric Vaccines SWOT Analysis 11.2.6 Merck Recent Developments 11.3 Pfizer 11.3.1 Pfizer Corporation Information 11.3.2 Pfizer Overview 11.3.3 Pfizer Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.3.4 Pfizer Pediatric Vaccines Products and Services 11.3.5 Pfizer Pediatric Vaccines SWOT Analysis 11.3.6 Pfizer Recent Developments 11.4 Sanofi 11.4.1 Sanofi Corporation Information 11.4.2 Sanofi Overview 11.4.3 Sanofi Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.4.4 Sanofi Pediatric Vaccines Products and Services 11.4.5 Sanofi Pediatric Vaccines SWOT Analysis 11.4.6 Sanofi Recent Developments 11.5 AstraZeneca 11.5.1 AstraZeneca Corporation Information 11.5.2 AstraZeneca Overview 11.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.5.4 AstraZeneca Pediatric Vaccines Products and Services 11.5.5 AstraZeneca Pediatric Vaccines SWOT Analysis 11.5.6 AstraZeneca Recent Developments 11.6 Novartis 11.6.1 Novartis Corporation Information 11.6.2 Novartis Overview 11.6.3 Novartis Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.6.4 Novartis Pediatric Vaccines Products and Services 11.6.5 Novartis Pediatric Vaccines SWOT Analysis 11.6.6 Novartis Recent Developments 11.7 Takeda Pharmaceutical 11.7.1 Takeda Pharmaceutical Corporation Information 11.7.2 Takeda Pharmaceutical Overview 11.7.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.7.4 Takeda Pharmaceutical Pediatric Vaccines Products and Services 11.7.5 Takeda Pharmaceutical Pediatric Vaccines SWOT Analysis 11.7.6 Takeda Pharmaceutical Recent Developments 11.8 Bavarian Nordic 11.8.1 Bavarian Nordic Corporation Information 11.8.2 Bavarian Nordic Overview 11.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.8.4 Bavarian Nordic Pediatric Vaccines Products and Services 11.8.5 Bavarian Nordic Pediatric Vaccines SWOT Analysis 11.8.6 Bavarian Nordic Recent Developments 11.9 Baxter 11.9.1 Baxter Corporation Information 11.9.2 Baxter Overview 11.9.3 Baxter Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.9.4 Baxter Pediatric Vaccines Products and Services 11.9.5 Baxter Pediatric Vaccines SWOT Analysis 11.9.6 Baxter Recent Developments 11.10 LG Life Sciences 11.10.1 LG Life Sciences Corporation Information 11.10.2 LG Life Sciences Overview 11.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.10.4 LG Life Sciences Pediatric Vaccines Products and Services 11.10.5 LG Life Sciences Pediatric Vaccines SWOT Analysis 11.10.6 LG Life Sciences Recent Developments 11.11 Lupin 11.11.1 Lupin Corporation Information 11.11.2 Lupin Overview 11.11.3 Lupin Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.11.4 Lupin Pediatric Vaccines Products and Services 11.11.5 Lupin Recent Developments 11.12 S K Chemicals 11.12.1 S K Chemicals Corporation Information 11.12.2 S K Chemicals Overview 11.12.3 S K Chemicals Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.12.4 S K Chemicals Pediatric Vaccines Products and Services 11.12.5 S K Chemicals Recent Developments 11.13 Mitsubishi Tanabe Pharma 11.13.1 Mitsubishi Tanabe Pharma Corporation Information 11.13.2 Mitsubishi Tanabe Pharma Overview 11.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.13.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Products and Services 11.13.5 Mitsubishi Tanabe Pharma Recent Developments 11.14 Janssen 11.14.1 Janssen Corporation Information 11.14.2 Janssen Overview 11.14.3 Janssen Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.14.4 Janssen Pediatric Vaccines Products and Services 11.14.5 Janssen Recent Developments 11.15 Shenzhen Kangtai Biological Products 11.15.1 Shenzhen Kangtai Biological Products Corporation Information 11.15.2 Shenzhen Kangtai Biological Products Overview 11.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.15.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Products and Services 11.15.5 Shenzhen Kangtai Biological Products Recent Developments 11.16 Sinovac Biotech 11.16.1 Sinovac Biotech Corporation Information 11.16.2 Sinovac Biotech Overview 11.16.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.16.4 Sinovac Biotech Pediatric Vaccines Products and Services 11.16.5 Sinovac Biotech Recent Developments 11.17 Bharat Biotech 11.17.1 Bharat Biotech Corporation Information 11.17.2 Bharat Biotech Overview 11.17.3 Bharat Biotech Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.17.4 Bharat Biotech Pediatric Vaccines Products and Services 11.17.5 Bharat Biotech Recent Developments 11.18 Crucell 11.18.1 Crucell Corporation Information 11.18.2 Crucell Overview 11.18.3 Crucell Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.18.4 Crucell Pediatric Vaccines Products and Services 11.18.5 Crucell Recent Developments 11.19 Dynavax 11.19.1 Dynavax Corporation Information 11.19.2 Dynavax Overview 11.19.3 Dynavax Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.19.4 Dynavax Pediatric Vaccines Products and Services 11.19.5 Dynavax Recent Developments 11.20 Serum Institute of India 11.20.1 Serum Institute of India Corporation Information 11.20.2 Serum Institute of India Overview 11.20.3 Serum Institute of India Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.20.4 Serum Institute of India Pediatric Vaccines Products and Services 11.20.5 Serum Institute of India Recent Developments 12 Value Chain and Sales Channels Analysis 12.1 Pediatric Vaccines Value Chain Analysis 12.2 Pediatric Vaccines Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Pediatric Vaccines Production Mode & Process 12.4 Pediatric Vaccines Sales and Marketing 12.4.1 Pediatric Vaccines Sales Channels 12.4.2 Pediatric Vaccines Distributors 12.5 Pediatric Vaccines Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Global Pediatric Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Diphtheria Table 3. Major Manufacturers of Influenza Table 4. Major Manufacturers of Hepatitis Table 5. Major Manufacturers of Pneumococcal Diseases Table 6. Major Manufacturers of Meningococcal Diseases Table 7. Major Manufacturers of Others Table 8. Global Pediatric Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 9. Global Pediatric Vaccines Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 10. Global Pediatric Vaccines Sales by Region (2017-2022) & (K Units) Table 11. Global Pediatric Vaccines Sales Market Share by Region (2017-2022) Table 12. Global Pediatric Vaccines Revenue by Region (2017-2022) & (US$ Million) Table 13. Global Pediatric Vaccines Revenue Market Share by Region (2017-2022) Table 14. Global Pediatric Vaccines Sales Forecast by Region (2023-2028) & (K Units) Table 15. Global Pediatric Vaccines Sales Market Share Forecast by Region (2023-2028) Table 16. Global Pediatric Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million) Table 17. Global Pediatric Vaccines Revenue Market Share Forecast by Region (2023-2028) Table 18. Top Pediatric Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2021 Table 19. Pediatric Vaccines Market Trends Table 20. Pediatric Vaccines Market Drivers Table 21. Pediatric Vaccines Market Challenges Table 22. Pediatric Vaccines Market Restraints Table 23. Global Pediatric Vaccines Sales by Manufacturers (2017-2022) & (K Units) Table 24. Global Pediatric Vaccines Sales Share by Manufacturers (2017-2022) Table 25. Global Pediatric Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million) Table 26. Ranking of Global Top Pediatric Vaccines Manufacturers by Revenue (US$ Million) in 2021 Table 27. Pediatric Vaccines Revenue Share by Manufacturers (2017-2022) Table 28. Global Pediatric Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) Table 29. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2021) Table 30. Key Manufacturers Pediatric Vaccines Average Selling Price (ASP) & (2017-2022) & (USD/Unit) Table 31. Key Manufacturers Pediatric Vaccines Plants/Factories Distribution Table 32. Key Manufacturers Pediatric Vaccines Area Served Table 33. Date of Key Manufacturers Enter into Pediatric Vaccines Market Table 34. Key Manufacturers Pediatric Vaccines Product Type Table 35. Mergers & Acquisitions, Expansion Plans Table 36. Global Pediatric Vaccines Sales (K Units) by Type (2017-2022) Table 37. Global Pediatric Vaccines Sales Share by Type (2017-2022) Table 38. Global Pediatric Vaccines Revenue (US$ Million) Market Share by Type (2017-2022) Table 39. Global Pediatric Vaccines Price (K Units) by Type (2017-2022) Table 40. Global Pediatric Vaccines Sales (K Units) by Type (2023-2028) Table 41. Global Pediatric Vaccines Sales Share by Type (2023-2028) Table 42. Global Pediatric Vaccines Revenue (US$ Million) Market Share by Type (2023-2028) Table 43. Global Pediatric Vaccines Revenue Share by Type (2023-2028) Table 44. Global Pediatric Vaccines Price (K Units) by Type (2023-2028) Table 45. Global Pediatric Vaccines Sales (K Units) by Application (2017-2022) Table 46. Global Pediatric Vaccines Sales Share by Application (2017-2022) Table 47. Global Pediatric Vaccines Revenue (US$ Million) Market Share by Application (2017-2022) Table 48. Global Pediatric Vaccines Price (K Units) by Application (2017-2022) Table 49. Global Pediatric Vaccines Sales (K Units) by Application (2023-2028) Table 50. Global Pediatric Vaccines Sales Share by Application (2023-2028) Table 51. Global Pediatric Vaccines Revenue (US$ Million) Market Share by Application (2023-2028) Table 52. Global Pediatric Vaccines Revenue Share by Application (2023-2028) Table 53. Global Pediatric Vaccines Price (K Units) by Application (2023-2028) Table 54. North America Pediatric Vaccines Sales by Company (2017-2022) & (K Units) Table 55. North America Pediatric Vaccines Sales Market Share by Company (2017-2022) Table 56. North America Pediatric Vaccines Revenue by Company (2017-2022) & (US$ Million) Table 57. North America Pediatric Vaccines Revenue Market Share by Company (2017-2022) Table 58. North America Pediatric Vaccines Sales by Type (2017-2022) & (K Units) Table 59. North America Pediatric Vaccines Sales by Type (2023-2028) & (K Units) Table 60. North America Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million) Table 61. North America Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million) Table 62. North America Pediatric Vaccines Sales by Application (2017-2022) & (K Units) Table 63. North America Pediatric Vaccines Sales by Application (2023-2028) & (K Units) Table 64. North America Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million) Table 65. North America Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million) Table 66. North America Pediatric Vaccines Sales by Country (2017-2022) & (K Units) Table 67. North America Pediatric Vaccines Sales by Country (2023-2028) & (K Units) Table 68. North America Pediatric Vaccines Revenue by Country (2017-2022) & (US$ Million) Table 69. North America Pediatric Vaccines Revenue by Country (2023-2028) & (US$ Million) Table 70. Europe Pediatric Vaccines Sales by Company (2017-2022) & (K Units) Table 71. Europe Pediatric Vaccines Sales Market Share by Company (2017-2022) Table 72. Europe Pediatric Vaccines Revenue by Company (2017-2022) & (US$ Million) Table 73. Europe Pediatric Vaccines Revenue Market Share by Company (2017-2022) Table 74. Europe Pediatric Vaccines Sales by Type (2017-2022) & (K Units) Table 75. Europe Pediatric Vaccines Sales by Type (2023-2028) & (K Units) Table 76. Europe Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million) Table 77. Europe Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million) Table 78. Europe Pediatric Vaccines Sales by Application (2017-2022) & (K Units) Table 79. Europe Pediatric Vaccines Sales by Application (2023-2028) & (K Units) Table 80. Europe Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million) Table 81. Europe Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million) Table 82. Europe Pediatric Vaccines Sales by Country (2017-2022) & (K Units) Table 83. Europe Pediatric Vaccines Sales by Country (2023-2028) & (K Units) Table 84. Europe Pediatric Vaccines Revenue by Country (2017-2022) & (US$ Million) Table 85. Europe Pediatric Vaccines Revenue by Country (2023-2028) & (US$ Million) Table 86. Asia Pacific Pediatric Vaccines Sales by Company (2017-2022) & (K Units) Table 87. Asia Pacific Pediatric Vaccines Sales Market Share by Company (2017-2022) Table 88. Asia Pacific Pediatric Vaccines Revenue by Company (2017-2022) & (US$ Million) Table 89. Asia Pacific Pediatric Vaccines Revenue Market Share by Company (2017-2022) Table 90. Asia Pacific Pediatric Vaccines Sales by Type (2017-2022) & (K Units) Table 91. Asia Pacific Pediatric Vaccines Sales by Type (2023-2028) & (K Units) Table 92. Asia Pacific Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million) Table 93. Asia Pacific Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million) Table 94. Asia Pacific Pediatric Vaccines Sales by Application (2017-2022) & (K Units) Table 95. Asia Pacific Pediatric Vaccines Sales by Application (2023-2028) & (K Units) Table 96. Asia Pacific Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million) Table 97. Asia Pacific Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million) Table 98. Asia Pacific Pediatric Vaccines Sales by Region (2017-2022) & (K Units) Table 99. Asia Pacific Pediatric Vaccines Sales by Region (2023-2028) & (K Units) Table 100. Asia Pacific Pediatric Vaccines Revenue by Region (2017-2022) & (US$ Million) Table 101. Asia Pacific Pediatric Vaccines Revenue by Region (2023-2028) & (US$ Million) Table 102. Latin America Pediatric Vaccines Sales by Company (2017-2022) & (K Units) Table 103. Latin America Pediatric Vaccines Sales Market Share by Company (2017-2022) Table 104. Latin America Pediatric Vaccines Revenue by Company (2017-2022) & (US$ Million) Table 105. Latin America Pediatric Vaccines Revenue Market Share by Company (2017-2022) Table 106. Latin America Pediatric Vaccines Sales by Type (2017-2022) & (K Units) Table 107. Latin America Pediatric Vaccines Sales by Type (2023-2028) & (K Units) Table 108. Latin America Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million) Table 109. Latin America Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million) Table 110. Latin America Pediatric Vaccines Sales by Application (2017-2022) & (K Units) Table 111. Latin America Pediatric Vaccines Sales by Application (2023-2028) & (K Units) Table 112. Latin America Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million) Table 113. Latin America Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million) Table 114. Latin America Pediatric Vaccines Sales by Country (2017-2022) & (K Units) Table 115. Latin America Pediatric Vaccines Sales by Country (2023-2028) & (K Units) Table 116. Latin America Pediatric Vaccines Revenue by Country (2017-2022) & (US$ Million) Table 117. Latin America Pediatric Vaccines Revenue by Country (2023-2028) & (US$ Million) Table 118. Middle East and Africa Pediatric Vaccines Sales by Company (2017-2022) & (K Units) Table 119. Middle East and Africa Pediatric Vaccines Sales Market Share by Company (2017-2022) Table 120. Middle East and Africa Pediatric Vaccines Revenue by Company (2017-2022) & (US$ Million) Table 121. Middle East and Africa Pediatric Vaccines Revenue Market Share by Company (2017-2022) Table 122. Middle East and Africa Pediatric Vaccines Sales by Type (2017-2022) & (K Units) Table 123. Middle East and Africa Pediatric Vaccines Sales by Type (2023-2028) & (K Units) Table 124. Middle East and Africa Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million) Table 125. Middle East and Africa Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million) Table 126. Middle East and Africa Pediatric Vaccines Sales by Application (2017-2022) & (K Units) Table 127. Middle East and Africa Pediatric Vaccines Sales by Application (2023-2028) & (K Units) Table 128. Middle East and Africa Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million) Table 129. Middle East and Africa Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million) Table 130. Middle East and Africa Pediatric Vaccines Sales by Country (2017-2022) & (K Units) Table 131. Middle East and Africa Pediatric Vaccines Sales by Country (2023-2028) & (K Units) Table 132. Middle East and Africa Pediatric Vaccines Revenue by Country (2017-2022) & (US$ Million) Table 133. Middle East and Africa Pediatric Vaccines Revenue by Country (2023-2028) & (US$ Million) Table 134. GlaxoSmithKline Corporation Information Table 135. GlaxoSmithKline Description and Overview Table 136. GlaxoSmithKline Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 137. GlaxoSmithKline Pediatric Vaccines Product and Services Table 138. GlaxoSmithKline Pediatric Vaccines SWOT Analysis Table 139. GlaxoSmithKline Recent Developments Table 140. Merck Corporation Information Table 141. Merck Description and Overview Table 142. Merck Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 143. Merck Pediatric Vaccines Product and Services Table 144. Merck Pediatric Vaccines SWOT Analysis Table 145. Merck Recent Developments Table 146. Pfizer Corporation Information Table 147. Pfizer Description and Overview Table 148. Pfizer Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 149. Pfizer Pediatric Vaccines Product and Services Table 150. Pfizer Pediatric Vaccines SWOT Analysis Table 151. Pfizer Recent Developments Table 152. Sanofi Corporation Information Table 153. Sanofi Description and Overview Table 154. Sanofi Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 155. Sanofi Pediatric Vaccines Product and Services Table 156. Sanofi Pediatric Vaccines SWOT Analysis Table 157. Sanofi Recent Developments Table 158. AstraZeneca Corporation Information Table 159. AstraZeneca Description and Overview Table 160. AstraZeneca Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 161. AstraZeneca Pediatric Vaccines Product and Services Table 162. AstraZeneca Pediatric Vaccines SWOT Analysis Table 163. AstraZeneca Recent Developments Table 164. Novartis Corporation Information Table 165. Novartis Description and Overview Table 166. Novartis Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 167. Novartis Pediatric Vaccines Product and Services Table 168. Novartis Pediatric Vaccines SWOT Analysis Table 169. Novartis Recent Developments Table 170. Takeda Pharmaceutical Corporation Information Table 171. Takeda Pharmaceutical Description and Overview Table 172. Takeda Pharmaceutical Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 173. Takeda Pharmaceutical Pediatric Vaccines Product and Services Table 174. Takeda Pharmaceutical Pediatric Vaccines SWOT Analysis Table 175. Takeda Pharmaceutical Recent Developments Table 176. Bavarian Nordic Corporation Information Table 177. Bavarian Nordic Description and Overview Table 178. Bavarian Nordic Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 179. Bavarian Nordic Pediatric Vaccines Product and Services Table 180. Bavarian Nordic Pediatric Vaccines SWOT Analysis Table 181. Bavarian Nordic Recent Developments Table 182. Baxter Corporation Information Table 183. Baxter Description and Overview Table 184. Baxter Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 185. Baxter Pediatric Vaccines Product and Services Table 186. Baxter Pediatric Vaccines SWOT Analysis Table 187. Baxter Recent Developments Table 188. LG Life Sciences Corporation Information Table 189. LG Life Sciences Description and Overview Table 190. LG Life Sciences Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 191. LG Life Sciences Pediatric Vaccines Product and Services Table 192. LG Life Sciences Pediatric Vaccines SWOT Analysis Table 193. LG Life Sciences Recent Developments Table 194. Lupin Corporation Information Table 195. Lupin Description and Overview Table 196. Lupin Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 197. Lupin Pediatric Vaccines Product and Services Table 198. Lupin Recent Developments Table 199. S K Chemicals Corporation Information Table 200. S K Chemicals Description and Overview Table 201. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 202. S K Chemicals Pediatric Vaccines Product and Services Table 203. S K Chemicals Recent Developments Table 204. Mitsubishi Tanabe Pharma Corporation Information Table 205. Mitsubishi Tanabe Pharma Description and Overview Table 206. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 207. Mitsubishi Tanabe Pharma Pediatric Vaccines Product and Services Table 208. Mitsubishi Tanabe Pharma Recent Developments Table 209. Janssen Corporation Information Table 210. Janssen Description and Overview Table 211. Janssen Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 212. Janssen Pediatric Vaccines Product and Services Table 213. Janssen Recent Developments Table 214. Shenzhen Kangtai Biological Products Corporation Information Table 215. Shenzhen Kangtai Biological Products Description and Overview Table 216. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 217. Shenzhen Kangtai Biological Products Pediatric Vaccines Product and Services Table 218. Shenzhen Kangtai Biological Products Recent Developments Table 219. Sinovac Biotech Corporation Information Table 220. Sinovac Biotech Description and Overview Table 221. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 222. Sinovac Biotech Pediatric Vaccines Product and Services Table 223. Sinovac Biotech Recent Developments Table 224. Bharat Biotech Corporation Information Table 225. Bharat Biotech Description and Overview Table 226. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 227. Bharat Biotech Pediatric Vaccines Product and Services Table 228. Bharat Biotech Recent Developments Table 229. Crucell Corporation Information Table 230. Crucell Description and Overview Table 231. Crucell Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 232. Crucell Pediatric Vaccines Product and Services Table 233. Crucell Recent Developments Table 234. Dynavax Corporation Information Table 235. Dynavax Description and Overview Table 236. Dynavax Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 237. Dynavax Pediatric Vaccines Product and Services Table 238. Dynavax Recent Developments Table 239. Serum Institute of India Corporation Information Table 240. Serum Institute of India Description and Overview Table 241. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 242. Serum Institute of India Pediatric Vaccines Product and Services Table 243. Serum Institute of India Recent Developments Table 244. Key Raw Materials Lists Table 245. Raw Materials Key Suppliers Lists Table 246. Pediatric Vaccines Distributors List Table 247. Pediatric Vaccines Customers List Table 248. Research Programs/Design for This Report Table 249. Key Data Information from Secondary Sources Table 250. Key Data Information from Primary Sources List of Figures Figure 1. Pediatric Vaccines Product Picture Figure 2. Global Pediatric Vaccines Sales Market Share by Type in 2021 & 2028 Figure 3. Diphtheria Product Picture Figure 4. Influenza Product Picture Figure 5. Hepatitis Product Picture Figure 6. Pneumococcal Diseases Product Picture Figure 7. Meningococcal Diseases Product Picture Figure 8. Others Product Picture Figure 9. Global Pediatric Vaccines Sales Market Share by Application in 2021 & 2028 Figure 10. Newborn Use Case Figure 11. Infant Use Case Figure 12. Child Use Case Figure 13. Dolescent Use Case Figure 14. Pediatric Vaccines Report Years Considered Figure 15. Global Pediatric Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 16. Global Pediatric Vaccines Market Size 2017-2028 (US$ Million) Figure 17. Global Pediatric Vaccines Sales (2017-2022) & (K Units) Figure 18. Global Pediatric Vaccines Market Size Market Share by Region: 2021 VS 2028 Figure 19. Global Pediatric Vaccines Sales Market Share by Region (2017-2022) Figure 20. Global Pediatric Vaccines Sales Market Share by Region in 2021 Figure 21. Global Pediatric Vaccines Revenue Market Share by Region in 2017 VS 2021 Figure 22. Global Pediatric Vaccines Sales Share by Manufacturers in 2021 Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Pediatric Vaccines Sales in 2021 Figure 24. Pediatric Vaccines Revenue Share by Manufacturers in 2021 Figure 25. Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 26. Global Pediatric Vaccines Revenue Share by Type (2017-2022) Figure 27. Global Pediatric Vaccines Revenue Growth Rate by Type in 2017 & 2021 Figure 28. Global Pediatric Vaccines Revenue Share by Application (2017-2022) Figure 29. Global Pediatric Vaccines Revenue Growth Rate by Application in 2017 & 2021 Figure 30. North America Pediatric Vaccines Sales Market Share by Type (2017-2028) Figure 31. North America Pediatric Vaccines Revenue Market Share by Type (2017-2028) Figure 32. North America Pediatric Vaccines Sales Market Share by Application (2017-2028) Figure 33. North America Pediatric Vaccines Revenue Market Share by Application (2017-2028) Figure 34. North America Pediatric Vaccines Sales Share by Country (2017-2028) Figure 35. North America Pediatric Vaccines Revenue Share by Country (2017-2028) Figure 36. U.S. Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 37. Canada Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 38. Europe Pediatric Vaccines Sales Market Share by Type (2017-2028) Figure 39. Europe Pediatric Vaccines Revenue Market Share by Type (2017-2028) Figure 40. Europe Pediatric Vaccines Sales Market Share by Application (2017-2028) Figure 41. Europe Pediatric Vaccines Revenue Market Share by Application (2017-2028) Figure 42. Europe Pediatric Vaccines Sales Share by Country (2017-2028) Figure 43. Europe Pediatric Vaccines Revenue Share by Country (2017-2028) Figure 44. Germany Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 45. France Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 46. U.K. Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 47. Italy Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 48. Russia Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 49. Asia Pacific Pediatric Vaccines Sales Market Share by Type (2017-2028) Figure 50. Asia Pacific Pediatric Vaccines Revenue Market Share by Type (2017-2028) Figure 51. Asia Pacific Pediatric Vaccines Sales Market Share by Application (2017-2028) Figure 52. Asia Pacific Pediatric Vaccines Revenue Market Share by Application (2017-2028) Figure 53. Asia Pacific Pediatric Vaccines Sales Share by Region (2017-2028) Figure 54. Asia Pacific Pediatric Vaccines Revenue Share by Region (2017-2028) Figure 55. China Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 56. Japan Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 57. South Korea Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 58. India Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 59. Australia Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 60. China Taiwan Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 61. Indonesia Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 62. Thailand Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 63. Malaysia Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 64. Latin America Pediatric Vaccines Sales Market Share by Type (2017-2028) Figure 65. Latin America Pediatric Vaccines Revenue Market Share by Type (2017-2028) Figure 66. Latin America Pediatric Vaccines Sales Market Share by Application (2017-2028) Figure 67. Latin America Pediatric Vaccines Revenue Market Share by Application (2017-2028) Figure 68. Latin America Pediatric Vaccines Sales Share by Country (2017-2028) Figure 69. Latin America Pediatric Vaccines Revenue Share by Country (2017-2028) Figure 70. Mexico Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 71. Brazil Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 72. Argentina Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 73. Colombia Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 74. Middle East and Africa Pediatric Vaccines Sales Market Share by Type (2017-2028) Figure 75. Middle East and Africa Pediatric Vaccines Revenue Market Share by Type (2017-2028) Figure 76. Middle East and Africa Pediatric Vaccines Sales Market Share by Application (2017-2028) Figure 77. Middle East and Africa Pediatric Vaccines Revenue Market Share by Application (2017-2028) Figure 78. Middle East and Africa Pediatric Vaccines Sales Share by Country (2017-2028) Figure 79. Middle East and Africa Pediatric Vaccines Revenue Share by Country (2017-2028) Figure 80. Turkey Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 81. Saudi Arabia Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 82. UAE Pediatric Vaccines Revenue (2017-2028) & (US$ Million) Figure 83. Pediatric Vaccines Value Chain Figure 84. Pediatric Vaccines Production Process Figure 85. Channels of Distribution Figure 86. Distributors Profiles Figure 87. Bottom-up and Top-down Approaches for This Report Figure 88. Data Triangulation Figure 89. Key Executives Interviewed

GlaxoSmithKline Merck Pfizer Sanofi AstraZeneca Novartis Takeda Pharmaceutical Bavarian Nordic Baxter LG Life Sciences Lupin S K Chemicals Mitsubishi Tanabe Pharma Janssen Shenzhen Kangtai Biological Products Sinovac Biotech Bharat Biotech Crucell Dynavax Serum Institute of India